Advanz Pharma Corp. buy melinda
Start price
12.08.16
/
50%
€2,570.4
Target price
13.02.17
€3,264.0
Performance (%)
-74.52%
End price
13.02.17
€654.84
Summary
This prediction ended on 13.02.17 with a price of €654.84. The BUY prediction by melinda for Advanz Pharma Corp. performed very badly with a performance of -74.52%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Advanz Pharma Corp. | - | - | - | - |
| iShares Core DAX® | 1,43 % | 1,58 % | 13,25 % | 61,14 % |
| iShares Nasdaq 100 | 1,89 % | -2,28 % | 2,99 % | 88,34 % |
| iShares Nikkei 225® | -1,62 % | 7,95 % | 27,69 % | 65,18 % |
| iShares S&P 500 | 1,92 % | -0,28 % | 2,99 % | 61,15 % |
Comments by melinda for this prediction
In the thread Advanz Pharma Corp diskutieren
erwartete Zunahme
a +
(Laufzeit überschritten)
Stopped prediction by melinda for Advanz Pharma Corp.
Advanz Pharma Corp.
Start price
Target price
Perf. (%)
€346.37
15.08.17
15.08.17
€405.90
19.12.17
19.12.17
-45.31%
19.12.17
19.12.17
Advanz Pharma Corp.
Start price
Target price
Perf. (%)
€384.00
15.08.17
15.08.17
€450.00
19.12.17
19.12.17
-45.31%
19.12.17
19.12.17